Do Hedge Funds and Insiders Love Halozyme Therapeutics, Inc. (HALO)?
Now, according to many investors, hedge funds are seen as delayed, outdated financial tools of an era lost to time.
Halozyme Therapeutics Inc. (HALO)
Market is closed
News
- First
- << Previous
- 61 - 70
- Next >>
Progenics Pharmaceuticals, Inc. (PGNX), Halozyme Therapeutics, Inc. (HALO), Astex Pharmaceuticals, Inc. (ASTX): Three Humongous Health-Care Stocks This Week
It was only a little over a year ago when Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) and partner Salix Pharmaceuticals, Ltd.
Baxter International Inc. (BAX), Halozyme Therapeutics, Inc. (HALO): This Healthcare Company Is Poised for Growth
The performance of Baxter International Inc. (NYSE:BAX), the world’s second-largest maker of dialysis products, has been lagging the market with 7.38% gain YTD as of Aug 2, 2013 compared to the 21....
Halozyme Therapeutics, Inc. (HALO), Viropharma Inc (VPHM): Three Horrendous Health-Care Stocks This Week
One decision led to a double whammy this week for biotech companies Halozyme Therapeutics, Inc. (NASDAQ:HALO) and Viropharma Inc (NASDAQ:VPHM).
Halozyme Therapeutics, Inc. (HALO): Is This Delivery-Focused Biotech a Buy?
Halozyme Therapeutics, Inc. (NASDAQ:HALO) moved higher by 25% on Friday behind the news of a positive opinion by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP...
Auxilium Pharmaceuticals, Inc. (AUXL): Huge Potential For First Line Therapy For Frozen Shoulder
Xiaflex from Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) is used to treat Dupuytren’s contracture.
Dyax Corp. (DYAX), Shire PLC (ADR) (SHPG): An Interesting Bio Play in the Blood Disorder Niche
Thousands of Americans suffer from a rare and painful disease every year. This inherited disease is called Hereditary Angioedema, or HAE for short.
Baxter International Inc. (BAX) Healthcare Stock Checkup
There is plenty of good news to support the 30% move made by Baxter International Inc. (NYSE:BAX) shares in the past year. The company's dividend has risen 44% in that time frame.
Here is What Hedge Funds Think About ACADIA Pharmaceuticals Inc. (ACAD)
To most market participants, hedge funds are viewed as underperforming, outdated financial vehicles of the past.
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock?
To the average investor, there are a multitude of metrics market participants can use to track stocks. A pair of the most useful are hedge fund and insider trading movement.
- First
- << Previous
- 61 - 70
- Next >>
Billionaire Hedge Funds
